Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme

Journal: Nature Communications

Published: 2017-12-04

DOI: 10.1038/s41467-017-01392-9

Affiliations: 20

Authors: 18

Go to article
Institutions FC
Humphrey Oei Institute of Cancer Research (HOICR), NCCS, Singapore 0.20
Division of Cellular and Molecular Research (CMR), NCCS, Singapore 0.20
VCU School of Medicine (SOM), United States of America (USA) 0.11
Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, United States of America (USA) 0.08
National Neuroscience Institute (NNI), Singapore 0.07
Department of Biomolecular Sciences, Saga University, Japan 0.06
Ludwig Institute for Cancer Research Ltd. (LICR), United States of America (USA) 0.06
Department of Pharmacoepidemiology, Kyoto University, Japan 0.06
School of Medical Science, Griffith University, Australia 0.03
Menzies Health Institute Queensland, Griffith University, Australia 0.03
VA North Texas Health Care System, United States of America (USA) 0.03
Duke-NUS Cancer and Stem Cell Biology Program (CSCB), Singapore 0.03
Children's Hospital Oakland Research Institute (CHORI), United States of America (USA) 0.02
NUS Department of Physiology, Singapore 0.01
NUS Department of Biochemistry (BCH), Singapore 0.01
Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore 0.01